Pricing Log in Create free account
Saturday 17 October 2026 Export MRK’s income statement to Excel — free account

Merck & Co., Inc.

MRK Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS fell 130.7%, free cash flow grew 77.0% and total debt rose 50.4%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for five.

145.95 0.76 +0.52%
Market cap
$358.2B
P/E
117×
Fwd P/E
53.9×
Dividend yield
2.33%
F-score
4/9
Altman Z
3.77
Beneish M
−2.27
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Merck & Co., Inc. (MRK) Book value per share

Alert me on Book value per share

Merck & Co., Inc.'s book value per share at the end of fiscal 2025 was 21.0×, up 14.9% from 18.3× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 17.0×. Over the past ten years it has ranged from 10.0× (fiscal 2020) to 21.0× (fiscal 2025) — the current reading is the highest in ten years. Merck & Co., Inc. ranks 9th of 21 Drug Manufacturers General companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 21.0× 14.93%
FY2024 18.3× 23.46%
FY2023 14.8× (18.45%)
FY2022 18.2× 20.30%
FY2021 15.1× 50.59%
FY2020 10.0× (0.94%)
FY2019 10.1× 0.46%
FY2018 10.1× (20.31%)
FY2017 12.7× (13.11%)
FY2016 14.6× (8.33%)

Quarterly newest first

Period Book value per share Change
Jun 2026 17.0× (8.52%)
Mar 2026 18.6× (11.72%)
Dec 2025 21.0× 1.17%
Sep 2025 20.8× 6.44%
42 more quarters

Against its own ten years

Low 10.0× High 21.0×
Ten-year median 14.8×
Current reading's percentile 100

Book value per share against peers

Company Book value per share
JNJ Johnson & Johnson compare 35.3×
AZN AstraZeneca PLC compare 32.5×
NVS Novartis AG compare 22.0×
AMGN Amgen Inc. compare 21.6×
MRK Merck & Co., Inc. 17.0×
PFE Pfizer Inc. compare 15.0×
GILD Gilead Sciences, Inc. compare 9.4×
NVO Novo Nordisk A/S compare 7.8×
ABBV AbbVie Inc. compare −3.3×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on MRK